EE: Ethinyl estradiol; LNG: Levonorgestrel; OC: Oral contraceptive; RR: Relative risk; VTE: Venous thromboembolism. Transdermal contraceptive patches provide a more convenient delivery system for ...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that six abstracts on its investigational low-dose estrogen combined hormonal contraceptive (CHC) weekly patch will be ...

The new labeling for the patch will include information about the higher levels of estrogen.The Ortho Evra contraceptive patch, produced by Ortho McNeil Pharmaceuticals, a unit of Johnson & Johnson ...

Astudy published Wednesday in the Journal of the American Medical Association shows women are more likely to use a new birth control patch than the pill. The new birth control patch is supposed to ...

Blood clot risk elevated with contraceptive patches, vaginal rings Women who use the combined contraceptive transdermal patch or vaginal ring are at significantly higher risk for venous thrombosis, ...

WASHINGTON -- Federal health officials approved sale of the world's first contraceptive patch yesterday, giving women an option considered as safe and effective as the pill but easier for some to use.

The patch supplies norelgestromin and ethinyl estradiol to the bloodstream through the skin. Has any evidence of genital swelling been documented with the use of the patch when placed inappropriately?

NEW YORK (Reuters Health) - Women who use a contraceptive patch appear to be more than twice as likely to develop a dangerous blood clot in their veins as those who use an oral contraceptive, new ...

WASHINGTON, Jan 18 (Reuters) - The label for a Johnson & Johnson contraceptive patch will include new data from a second study showing a higher risk of blood clots compared with birth-control pills, U ...